Health Sciences Authority - List of Revised Fees (from 1 January 2011)

Home > Health Products Regulation > Licences & Fees > List of Revised Fees (from 1 January 2011)

List of Revised Fees (from 1 January 2011)

Medicinal Products- Product Licence

Revised Fee (S$) (from 1 Jan'11)
1	Application for a Licence- NDA & GDA
	a)	Screening
		(i) Abridged/Verification Dossier (NDA & GDA)	550
		(ii) Full Dossier (NDA)	2,750
	b)	Evaluation
		(i) GDA Dossier
		- GDA-1	3,850
		- GDA-2	2,200
		(ii) Abridged (NDA) Chemical Drugs & Biologics
		- NDA-1 & NDA-2	11,000
		- NDA-3	5,500
		(iii) Verification (NDA) Chemical Drugs & Biologics
		- NDA-1 & NDA-2	16,500
		- NDA-3	5,500
		(iv) Full Dossier (NDA)	82,500
2	Application to amend a licence
	a)	MAV1 - Chemical Drugs & Biologics
		(i) Evaluation
		- Abridged Evaluation for First Strength	5,500
		- Verification Evaluation for First Strength	8,250
		- Abridged/Verification Evaluation For a Subsequent Strength	2,750
		- Full Dossier	51,000
	b)	MIV-1 - Chemical Drugs & Biologics	550

Cosmetic Products - Annual Notification

1	Cosmetic Products deemed to be of higher risk¹
	a)	Single product	25
	b)	Variant
		(i) First 3 variants	25/variant
		(ii) 4^th and subsequent variants	5/variant
2.	Cosmetic Products deemed to be of lower risk²
	a)	Single product	10
	b)	Variant
		(i) First 3 variants	10/variant
		(ii) 4^th and subsequent variants	5/variant

^{For retention on the cosmetic product, the above fee is applicable.}

¹Cosmetic Products deemed to be of higher risk are cosmetic products to be applied around the eyes, on the lips, hair dyes containing phenylenediamines and oral and dental care products.

²Cosmetic Products deemed to be of lower risk are all other cosmetic products not listed above such as skin whitening products, moisturisers, etc.

Last updated on 17 Mar 2011 18:02:08